|
Market Cap (24-Jun) $110,470,648 (1,377th) |
Close (30-Jun) $0.028 |
Volume (30-Jun) 622,600 |
Shortsold (30-Dec) 421 (0.00%) (625th) |
|
52w High $1.44 |
52w Low $0.225 |
P/E - |
EPS -0.02 |
NYR released this announcement to the ASX on 5 September 2022, 8:21. The announcement is not marked as price sensitive, and is 27 page(s) in length and 2.11MB in size.
You can view all announcements from NYR and see how they appear on a price chart on the announcements page.
At the date of this announcement, NYR was 0.001% short sold according to ASIC data. It was ranked the 633rd most shorted stock on the ASX. It is now ranked as the 625th most shorted stock on the ASX with 0.000% of total shares short sold as of the latest reported data (30 December 2025).
| Other Recent Announcements from NYR | |
|---|---|
| Cholesterol-Lowering Program Update | 26 June 2023, 9:55 |
| Brain Injury Program Preclinical Development Update | 9 June 2023, 8:18 |
| Cholesterol-Lowering Program Preclinical Studies Completed | 26 May 2023, 8:44 |
| Presentation to E&P Small Caps Health Care Conference | 5 September 2022, 8:21 |
| Nyrada Reports Full Year FY2022 Results | 29 August 2022, 18:17 |
| Annual Report to June 30 2022 | 29 August 2022, 18:14 |
| Preliminary Final Report | 29 August 2022, 18:10 |
You must be logged in to post a reply.
Nyrada Inc 